发明申请
- 专利标题： Aminopyridine Derived Compounds as LRRK2 Inhibitors
- 专利标题（中）： 氨基吡啶衍生化合物作为LRRK2抑制剂
-
申请号： US15071955申请日： 2016-03-16
-
公开(公告)号： US20160184317A1公开(公告)日： 2016-06-30
- 发明人: Gitte Kobberøe Mikkelsen , Laurent David , Stephen Watson , Garrick Paul Smith , Douglas Stewart Williamson , I-Jen Chen
- 申请人： H. Lundbeck A/S , Vernalis (R&D) Ltd.
- 申请人地址： DK Valby GB Winnersh
- 专利权人： H. Lundbeck A/S,Vernalis (R&D) Ltd.
- 当前专利权人： H. Lundbeck A/S,Vernalis (R&D) Ltd.
- 当前专利权人地址： DK Valby GB Winnersh
- 优先权： DKPA201300004 20130102; DKPS201300136 20130311
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; A61K31/4545 ; A61K31/497 ; A61K31/4439
摘要：
The present invention is directed to aminopyridine derived compounds of formula (A) The compounds are considered useful for the treatment of diseases associated with LRRK2 such a Lewy body dementia, Parkinson's disease or cancer.
公开/授权文献
- US09393248B1 Aminopyridine derived compounds as LRRK2 inhibitors 公开/授权日：2016-07-19
信息查询
IPC分类:
